Ignite Creation Date:
2025-12-25 @ 4:47 AM
Ignite Modification Date:
2025-12-26 @ 3:49 AM
Study NCT ID:
NCT01462318
Status:
COMPLETED
Last Update Posted:
2017-03-14
First Post:
2011-07-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-14
First Submit QC Date:
None
Study First Post Date:
2011-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-23
Results First Submit QC Date:
None
Results First Post Date:
2017-03-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-10-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-01-23
Last Update Post Date:
2017-03-14
Last Update Post Date Type:
ACTUAL